XML 43 R2.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Balance Sheets - USD ($)
May. 31, 2015
Feb. 28, 2015
Feb. 28, 2014
CURRENT ASSETS      
Cash and cash equivalents $ 1,032,563 $ 257,820 $ 483,408
Other receivable     20,000
Prepaid expenses 159,860 $ 38,748 12,073
Deferred financing cost     60,523
Assets held for sale 85,196    
Total Current Assets 1,277,619 $ 296,568 576,004
Equipment (net of accumulated depreciation of $96,089 and $34,194, respectively) 514,487 526,606 204,254
Refundable deposit 281,052 (278,952) (10,367)
TOTAL ASSETS 2,073,158 1,102,126 790,625
Current liabilities      
Accounts payable 336,534 293,152 $ 257,965
Accrued expense 129,179 4,565  
Current portion of capital lease $ 102,773 $ 99,965  
Convertible notes (net of discount of $206,636)     $ 2,475,717
Accrued interest payable   $ 2,351 $ 137,701
Accrued dividends on Series B Preferred Stock $ 45,530 16,767  
Total Current Liabilities 614,016 416,800 $ 2,871,383
Capital lease 142,870 169,676  
Warrant liability 136,500 273,000  
TOTAL LIABILITIES 893,386 859,476 $ 2,871,383
STOCKHOLDERS' EQUITY (DEFICIT)      
Common Stock, ($0.0001 par value; 150,000,000 shares authorized; 27,470,960 and 21,573,899 shares issued and outstanding respectively) 2,763 2,747 2,157
Additional Paid-in-capital 20,974,978 18,962,965 8,644,760
Accumulated deficit (19,798,056) (18,723,149) (10,727,675)
Total stockholders' equity (Deficit) 1,179,772 242,650 (2,080,758)
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY $ 2,073,158 1,102,126 $ 790,625
Series A Preferred Stock      
STOCKHOLDERS' EQUITY (DEFICIT)      
Preferred: Series A convertible preferred stock ($0.0001 par value; 1,000,000 shares authorized; 847,257 and 0 shares issued and outstanding resectively) Series B convertible preferred stock ($0.0001 par value; 1,000 shares authorized; 229 and 0 shares issued and outstanding resectively)   $ 87  
Series B Preferred Stock [Member]      
STOCKHOLDERS' EQUITY (DEFICIT)      
Preferred: Series A convertible preferred stock ($0.0001 par value; 1,000,000 shares authorized; 847,257 and 0 shares issued and outstanding resectively) Series B convertible preferred stock ($0.0001 par value; 1,000 shares authorized; 229 and 0 shares issued and outstanding resectively)